Senior insider sale
SVP & PAO at ASCENDIS PHARMA A/S — senior position signals high conviction
$2.38M
10K shares
What this filing means
BODENHOFF MADS plans to sell 10K shares of ASCENDIS PHARMA A/S valued at approximately $2.38M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/6/2026ACC: 0001964306-26-000155
Officer· SVP & PAO
Since Mar 2026
10K
Shares to sell
$2.38M
Approx. market value
10K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Warrant exercise
Cash
3/6/2026
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/6/2026 | Warrant exercise Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10K
Market value
$2.38M
3/6/2026
Total
Units
10K
Value
$2.38M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/6/2026 | 10K | $2.38M | NASDAQ | Planned |
| Total | 10K | $2.38M | ||